微譜生物科技是微譜科技集團(tuán)在生物藥領(lǐng)域的重要戰(zhàn)略布局。微譜生物科技立足于生物醫(yī)藥全產(chǎn)業(yè)鏈，致力于為國(guó)內(nèi)外生物藥企業(yè)提供合規(guī)、專業(yè)、一體化的生物制品質(zhì)量與安全研究綜合解決方案，擁有成功項(xiàng)目經(jīng)驗(yàn)超500個(gè)。目前，我們的實(shí)驗(yàn)室已經(jīng)成功通過(guò)美國(guó)FDA官方現(xiàn)場(chǎng)檢查，未來(lái)微譜生物科技還將繼續(xù)接軌全球生物藥企業(yè)需求，專注打造國(guó)際合規(guī)的生物安全檢測(cè)平臺(tái)，全力支持客戶高效推進(jìn)中美歐等項(xiàng)目多報(bào)。

Weipu Biotechnology is an important strategic layout of Micro Spectrum Technology Group in the field of biopharmaceuticals. Micro Spectrum Biotechnology is based on the entire biopharmaceutical industry chain, committed to providing compliant, professional, and integrated comprehensive solutions for the quality and safety research of biological products for domestic and foreign biopharmaceutical enterprises, with over 500 successful project experiences. At present, our laboratory has successfully passed the official on-site inspection of the US FDA. In the future, Weipu Biotechnology will continue to meet the needs of global biopharmaceutical companies, focus on building an internationally compliant biosafety testing platform, and fully support customers in efficiently promoting projects such as China, the United States, and Europe.